Sun Pharma Advanced Research Company Limited Share Price & Technical Analysis
SPARC · ₹208.5 (+2.09%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹208.5
+2.09%
Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology and immunology. The company is also developing Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia tha…
Price chart
Seasonality
Jun has 2 positive and 3 negative years (last 5 years shown)
-2% return in Jun, 3% avg return in past 3 year Jun month.
45% return in 2026, -5% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -6% | -7% | -8% | 19% | 48% | -2% | – | – | – | – | – | – | 45% |
| 25 | -20% | -29% | 32% | 0% | 26% | -13% | -8% | -7% | -8% | 4% | -1% | 0% | -23% |
| 24 | 33% | -4% | 1% | -36% | -7% | 11% | -5% | -5% | -3% | -1% | 0% | -8% | -25% |
| 23 | -4% | -5% | -6% | 8% | -3% | 10% | 14% | 6% | -10% | -2% | 20% | 4% | 32% |
| 22 | 9% | -15% | 11% | -11% | -14% | -7% | 9% | 1% | -3% | 16% | -4% | -17% | -26% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Strong
Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology and immunology. The company is also developing Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia that is in phase 2 clinical trial; and Vibozilimod (SCD-044), a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist, for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial. In addition, it develops SCD-153 for the treatment of alopecia areata; and SBO-154, an anti-MUC-1 ADC, for the treatment of multiple tumors that is in preclinical trials. The company was incorporated in 2006 and is based in Mumbai, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹66.28B
P/E ratio
4.27
52W high
₹248.8
52W low
₹108.0
Volume
48,47,149
Beta
0.35
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,732
Frequently asked questions
- What is Sun Pharma Advanced Research Company Limited share price today?
- Sun Pharma Advanced Research Company Limited (SPARC) last traded around ₹208.5 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SPARC have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SPARC. Download the app for real-time alerts.
- How can I analyze Sun Pharma Advanced Research Company Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.